Scientific programme

Scientific Programme

This Congress will showcase a plethora of relevant topics in the exciting field of Transfusion Medicine, from recruitment of blood donors to the actual donation process, biology of blood cells, preparation of blood components, transfusion-transmitted infectious diseases, immunohaematology patient blood management, adverse transfusion events, cellular therapies, and much more. There will be workshops on peer reviewing and clinical transfusion research. Special sessions will be organized for transfusion practitioners. We will once again hold a Young Investigators breakfast session.

The Nordic day will focus on topics that are relevant to the region and the highly educational Academy day gives you the opportunity to refresh your knowledge and/or hear summaries of interesting research findings from vein to vein. 

The complete scientific programme will be available online soon.

Young Investigators Scientific Session

After a successful first session in Dubai, a second Young Investigator session will be organized at the 27th Regional Congress in Copenhagen. 

If you would like your abstract to be considered for oral presentation in this session, please indicate this during the abstract submission process.

You should be undertaking research in a topic related to transfusion medicine and you must meet the following requirements:

  • Be 35 years of age or under (proof of age will be required if successful)
  • Attending the congress and presenting the submitted work if selected
  • And be working towards a PhD or a Masters degree, and/or undertaking high level research 


09.00 - 10.40Possible tasks and new areas for blood banks
09.00 - 09.25Pathogen reduction - what are the advantages, what are the problems, what are the costs?
F. Knudson (Sweden)
09.25 - 09.50HPA-1a antibody screening in pregnancy: is it possible and what are the potential outcomes?
J. Kjeldsen-Kragh (Sweden)
09.50 - 10.15Advanced therapy medicinal products (ATMP) - the role of the blood bank
A. Fischer-Nielsen (Denmark)
10.15 - 10.40Personalized transfusion medicine
S. R. Ostrowski (Denmark)
10.40 - 11.00Coffee Break
11.00 - 12.00Use and future use of blood donor and transfusion databases
11.00 - 11.20Perspectives and opportunities for the Danish Blood Donor Study
C. Erikstrup (Denmark)
11.20 - 11.40Perspectives and opportunities for the Danish Transfusion Database
K. E. Titlestad (Denmark)
11.40 - 12.00Perspectives and opportunities for SCANDAT
G. Edgren (Sweden)
12.00 - 13.00Lunch Break
13.30 - 15.00Plasma derived medicinal products and self-sufficiency
13.30 - 14.30Council of Europe's work on Plasma Supply Management
R. Norda (Denmark)
14.30 - 15.00Towards plasma self-sufficiency - the process and the status in Denmark
M. Bagge Hansen (Denmark)
15.00 - 15.30Coffee Break
15.30 - 16.30Blood supply management in the future
15.30 - 16.00Where and how to collect blood in a changing world
J. Georgsen (Denmark)
16.00 - 16.30Centralised blood establishment - what are the advantages
M. Syrjälä / J. Ihalainen (Finland)
09.00 - 10.30Donors and Donation
09.00 – 09.30The Young Donor
A. Eder (USA)
09.30 – 10.00The Older Donor
M. Goldman (Canada)
10.00 – 10.30The Deferred Donor
V. Compernolle (Canada)
09.00 - 10.30 
Transfusion Therapy
09.00 – 09.30Hemolytic disease of the fetus and newborn (HDFN): the transfusion perspective
E. Muñiz Diaz (Spain) 
09.30 – 10.00 HDFN: the maternal-fetal medicine / obstetric perspective
M. Hedegaard (Denmark)
10.00 – 10.30 HDFN: the neonatology perspective
E. Lopriore (The Netherlands)
10.30 - 11.00 Coffee break
11.00 - 12.30 
Organisation and Quality, Clinical Governance
11.00 – 11.30  The role of the national blood transfusion committee
M. Murphy (UK)
11.30 – 12.00 The role of the hospital transfusion committee
S. Nahirniak (Canada) 
12.00 – 12.30  Clinical governance in the blood service
G. Miflin (UK)
11.00 - 12.30 
11.00 – 11.30 New laboratory tools for immunohaematology: correlating flow cytometry and molecular results
A. Hult (Sweden) 
11.30 – 12.00  Managing a rare donor program – the immunohaematology laboratory perspective
C. Paccapelo (Italy)
12.00 – 12.30 Challenging Red Cell Serology Cases
S. Lejon-Crottet (Switzerland) 
12.30 - 13.30 Lunch Break
13.30 - 15.00TTID
13.30 – 14.00  New infectious epidemics: the global health view
M. Nübling (Sweden)
14.00 – 14.30 Modelling risks of emerging infectious diseases relevant to blood transfusion
M. Janssen (The Netherlands) 
14.30 – 15.00Effectiveness of pre-donation health and travel screening in reducing the risk of TTIs
C. Erikstrup (Denmark)
13.30 - 15.00Clinical Transfusion Practice
13.30 – 14.00 Making Transfusion Decision in Critical Care
C. Aubron (France) 
14.00 – 14.30 European Collaborative Initiatives in PBM
M. Bruun (Denmark) 
14.30 – 15.00 The Transfusion Practitioner in the multidisciplinary team
J. Grant-Casey (UK)
15.00 - 15.30Coffee Break
15.30 - 17.00Blood Components and Supply Management
15.30 – 16.00  Red Cell Apheresis: Pros and Cons
L. Infanti (Switzerland)
16.00 – 16.30Do we need cryoprecipitate in the era of fibrinogen concentrate and other specific factor replacement options?
N. Curry (UK) 
16.30 – 17.00 Implementing a comprehensive blood wastage reduction programme
M. Yazer (US) 
15.30 - 17.00Cellular Therapy
15.30 – 16.00 The role of the transfusion physician in supporting cellular therapies
M. Lozano (Spain) 
16.00 – 16.30 HSCT for non-malignant diseases
V. Potter (UK)
16.30 – 17.00 Will we still need HSCT in the era of targeted therapies?
L. Burns (USA) 



07.00 - 08.15Young Investigator Breakfast Session
08.30 - 10.00Challenges of terrorism and catastrophies, too much or too little blood
08.30 - 09.00 Lessons learned from Paris and Nice
S. Noel (France) 
09.00 - 09.30 Lessons learned from Brussels
V. Compernolle (Belgium)
09.30 - 10.00Contingency planning in general - Results of an EBA WG
A. Kelly (Ireland)
08.30 - 10.00Late breaking Zika session
08.30 - 10.00Oral presentations
08.30 - 10.00Clinical use of immunoglobulin
08.30 - 09.00  Clinical use of immunoglobulin in neurology
H. Andersson (Denmark)
09.00 - 10.00 Selected abstracts
08.30 - 10.00CAR T cells
08.30 - 09.00 New Technologies and Applications for CAR T therapy
M. Hudecek (Germany) 
09.00 - 09.30  Adoptive cell therapy based on tumour infiltrating lymphocytes
I. M. Svane (Denmark)
09.30 - 10.00Selected Abstracts
08.30 - 10.00Antenatal determination of fetal blood groups or antigens
08.30 - 09.00State of the art of prenatal genotyping in different countries
M. de Haas (Netherlands) 
09.00 - 10.00 Selected abstracts
10.00 - 10.30Coffee Break
10.30 - 12.00Plenary Session I: Major Bleeding
10.30 - 11.00 Damage control resuscitation - how to use blood products and manage major bleeding trauma
M. Schreiber (USA)
11.00 - 11.30Direct oral anticoagulants (DOACS) induced bleeding - update on antidotes and treatment
D. Faraoni (Canada)
11.30 - 12.00Pathophysiology of massive haemorrhage 
J. Stensballe (Denmark)
12.00 - 14.00Lunch Break



14.00 - 15.30Benchmarking
14.00 - 14.30 Benchmarking; Principles and Pitfalls
P. Bogetoft (Denmark)
14.30 - 15.00  Benchmarking in Blood Transfusion: Where are we now?
S. Morgan (UK)
15.00 - 15.30Selected Abstracts
14.00 - 15.30Blood Safety
14.00 - 15.30Selected Abstracts
14.00 - 15.30Coagulopathy of Acute Critical Illness
14.00 - 14.30  Endotheliopathy
P. Johansson (Denmark)
14.30 - 15.30Selected abstracts
14.00 - 15.30Mesenchymal Stem Cells
14.00 - 14.30 From the laboratory bench to the patient's bedside: an update of clinical trials with MSCs
A. Giordano (Italy)
14.30 - 15.00 Selected abstracts
14.00 - 15.30Alloantibodies in transfusion medicine
14.00 - 14.30 Anti-endothelial avB3 antibodies are a major cause of intracranial bleeding in FNAIT
U. Sachs (Germany) 
14.30 - 15.30 Selected abstracts
14.00 - 15.30The Transfusion Practitioner effect on PBM adoption and implementation 
This session will look at aspects of PBM, and how the TP plays a vital role in the team to effect change.
15.30 - 16.00Coffee Break



16.00 - 17.30Donor health
16.00 - 16.30Donor Fainting
P. Tiberghien (France)
16.30 - 17.30Selected abstracts
16.00 - 17.30Alternative treatments
16.00 - 16.30
Platelets in liver regeneration
J. Meyer (Switzerland)
16.30 - 17.30Selected abstracts
16.00 - 17.30So much more than clots
16.00 - 16.30
Blood products so much more than clots and oxygen delivery
S. Ostrowski (Denmark)
16.30 - 17.30Selected abstracts
16.00 - 17.30Haemoglinopathies in the developing world
16.00 - 16.30Practical experiences
O. Nnodu (Nigeria)
16.30 - 17.00Perinatal screening programme on Sickle Cell Disease
A. Osei-Akota (Ghana)
17.00 - 17.30Epidemiology
To be confirmed
16.00 - 17.30The HLA system in transfusion
16.00 - 16.30 Clinical relevance of the HLA system in blood transfusion
C. Brown (UK) 
16.30 - 17.00 PIRCHE technology
To be confirmed 
17.00 - 17.30 To be confirmed
15.30 - 17.30Transfusion Practitioners Session
Afternoon tea, networking, Q&A Session
17.30 - 18.30Poster Session



08.30 - 10.00Plasma supply management
08.30 - 09.00  Safe and sustainable plasmapheresis
J. Pink (Australia)
09.00 - 09.30 Self-sufficiency in plasma supply
P. Flanagan (New Zealand) 
09.30 - 10.00 The future for plasma collection
P. Strengers (Netherlands) 
08.30 - 10.00NAT v HBsAg
08.30 - 09.00Value of HBsAg donor screening beside HBV-NAT and/or anti-HBcore screening
C. Seed (Australia)
09.00 - 09.30To be confirmed
09.30 - 10.00To be confirmed
08.30 - 10.00Back to the future - is there a role for whole blood transfusions
08.30 - 09.00 Whole blood for hemostatic resuscitation of major bleeding in traumatic hemorrhagic shock
G. Strandenes (Norway)
09.00 - 09.30 Cold stored v.s. room temp. stored platelets
T.O. Apelseth (Norway) 
09.30 - 10.00 To be confirmed
08.30 - 10.00Young Investigators Session
08.30 - 10.00Metabolomics in bloodbanking and Transfusion Medicine
08.30 - 09.00Metabolomic analysis of blood storage
O. Sigurjonsson (Iceland) 
09.00 - 09.30 Biomarkers defining the metabolic age of red blood cells during cold storage
B. Palsson (Iceland/USA) 
09.30 - 10.00 Role of extra microvesicles in relation to TM 
E. Boilard (Canada)
10.00 - 10.30Coffee Break
10.30 - 12.00Plenary Session II: To be confirmed
10.30 - 11.00Hepatitis E
H. Zaaijer (The Netherlands)
11.00 - 11.30To be confirmed
11.30 - 12.00CRISPR technology
D. Higgs (UK)
12.00 - 14.00Lunch break
14.00 - 15.30Clinical transfusion in the Developing World
14.00 - 14.30 To be confirmed
14.30 - 15.00 The benefits and challenges of doing research within a network
C. Tangy Tayou (Cameroon) 
15.00 - 15.30  Blood cell storage under usual conditions in Africa
S. Uyoga (Uganda)
14.00 - 15.30Pathogenicity of transfusion-transmitted arboviruses
14.00 - 14.30Host inflammatory response to mosquito bites enhances the severity of arbovirus infection
C. McKimmie (UK)
14.30 - 15.00To be confirmed
15.00 - 15.30To be confirmed
14.00 - 15.30Clinical
14.00 - 14.30Steps to setting up a paediatric PBM programme and the unique paediatric specific challenges
R. Goel (USA)
14.30 - 15.30Selected abstracts
14.00 - 15.30Storage Leakage
14.00 - 14.30To be confirmed
14.30 - 15.30Selected abstracts
14.00 - 15.30Genotyping
14.00 - 14.30To be confirmed
14.30 - 15.30Selected abstracts
15.30 - 16.00Coffee Break



16.00 - 17.30Healthy donor effect
16.00 – 16.30 Donor management
M. Clement (Germany) 
16.30 - 17.30 Selected abstracts
16.00 - 17.30Blood Safety
16.00 - 17.30Selected abstracts
16.00 - 17.30Total laboratory automation
16.00 – 16.30 Total Laboratory Automation
M. Schmidt (Germany) 
16.30 - 17.30Selected abstracts
16.00 - 17.30Growing Blood
16.00 - 16.30 How to culture red blood cells for transfusion
A. Toye (UK)
16.30 – 17.30 Selected abstracts
16.00 - 17.30Platelets
16.00 - 16.30Platelet immunobiology
J. Semple (Sweden)
16.30 - 17.00To be confirmed
17.00 - 17.30To be confirmed
19.30 - 23.30Congress Party
08.30 - 10.00Donor Psychology
08.30 – 09.00  Tracking the emotional journey of the blood donor
B. Masser (Australia)
09.00 - 10.00Selected abstracts
08.30 - 10.00Impacts on testing
08.30 – 09.00 Effect of climate change on donor testing
J. Semenza (Sweden)
09.00 - 10.00Selected abstracts 
08.30 - 10.00Patient Blood Management
08.30 - 09.00 One unit too much or one unit too few - which gives the least risk to the patient? 
E. Seifried (Germany)
09.00 - 10.00Selected abstracts
08.30 - 10.00Improving blood transfusion in the developing world
08.30 – 09.00 Experiences from the field
P. Zakharias (South Africa) 
09.00 – 09.30  The organisation of blood centres in Namibia
I. Chipare (Namibia)
09.30 – 10.00 Motivating donors in Ghana
L. Asamoah (Ghana) 
08.30 - 10.00Immunity against transfused red cells
08.30 - 09.00To be confirmed
09.00 - 09.30To be confirmed
09.30 – 10.00 Red Blood Cell Alloimmunisation: Induction of Immunity and Potential Mitigation Strategies
J. Hendrickson (USA) 
10.00 - 10.30 Coffee Break



10.30 - 12.00Plenary Session III: Blood Donor Studies and Big Data
10.30 - 11.00UK interval study
D. Roberts (UK)
11.00 - 12.00To be confirmed
Closing Ceremony

Farewell Lunch



Monday 19th June 14:00-15:30
The Transfusion Practitioner effect on PBM adoption and implementation

This session will look at aspects of PBM, and how the TP plays a vital role in the team to effect change.

Monday 19 June 15:30-17:30
TP afternoon tea, networking and Q&A session

You are invited to join other TPs for afternoon tea, and then stay on for an interesting and interactive networking and Q&A session. At this session you will hear about, and discuss the many aspects of the TP role related to PBM and blood transfusion practice, including tips and tools with a wide range of TPs and clinical specialists. Come along, join in the sharing and learning.

ISBT is looking for early career scientists who are willing to be reviewers for papers in Vox Sanguinis, the ISBT Science Series and submitted congress abstracts. Therefore, we will host a workshop (Monday June 19, 8.30-10.00 hrs) on peer review during the congress.

Peer review is the method by which grants are allocated, papers published and much more. Yet there is very little training in peer review, often it is up to the new reviewer to find their own way around the joys and difficulties of the review process.

Becoming involved in peer review can be very informative, help you with your own scientific writing and be a career enhancing experience. It is an opportunity to get yourself on the map and a good addition to your c.v.

The workshop is open to early career scientists who wish to offer themselves as peer reviewers and to find out how to navigate around the process. It is also open to current reviewers who wish to refresh their reviews or find out more about peer review within ISBT.

To express an interest in attending the workshop, please complete the application form and return it to

Closing date for applications is 10 May, 2017.

Monday June 19, 2017

7.00-8.15 hrs
The Treehouse, Bella Center

A breakfast is organized to informally bring Young Investigators together with Transfusion Medicine experts. The breakfast is held at the Treehouse restaurant which is a part of the Bella Center, and located in hall E North on the first floor. 

Complete the application form which you can download here and send it to

Please keep in mind that there are up to 50 places available.

“I attended the Young Investigator Breakfast, which was very rewarding. Researchers and experts from different countries sat next to each other exchanging ideas, experiences and challenges” G. Wu
“One of the highlights of the congress was meeting mentors and being able to chat with them at the Young Investigators breakfast” K. Winter

* Each parallel session will comprise (an) invited speaker(s) and selected abstracts for oral presentation.



“I think ISBT is the main forum for translating science and networking into best practices”

Morten Bagge Hansen, Denmark
Become a member from 55,- euro p/y Join us now